News Releases Aug 01 2023 Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital May 08 2023 EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results View All News View All Events May 08 2023 at 4:30 PM EDT May 08 2023 at 4:30 PM EDT Q1 2023 Financial Results View All Events View All Presentations and FAQs Aug 01, 2023 Transaction with Revolution Medicines: Investor FAQ May 08, 2023 Q1 2023 Presentation 1.7 MB View All Events View All
Aug 01 2023 Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital
May 08 2023 EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results